Our study aimed to assess the density of selected immune cell subsets present in both intratumoral and peritumoral benign (non-tumor) regions of primary prostate cancer specimens, and to examine the association of immune cell subsets with biochemical recurrence (BCR) and the development of metastatic disease following radical prostatectomy. The gene discussed is BCR; the disease is prostate cancer.